Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Stef Stienstra

Stef Stienstra

Scientific Advisor Royal Dutch Navy, Netherlands

Title: Cooperation in public health to fight infectious diseases in developing countries is good for the global economy

Biography

Biography: Stef Stienstra

Abstract

Public health systems are not always prepared for outbreaks of infectious diseases. Although in the past several public health institutes, like the French ‘Institut Pasteur’ and the Dutch ‘Tropeninstituut ‘, were prominent surveyors of infectious diseases, the investments in worldwide public health have decreased. Now more attention is given to curative healthcare compared to preventive healthcare. The recent Ebola Virus Disease outbreak in West Africa initiated a new wave of interest to invest in Worldwide Public Health to prevent outbreaks of highly contagious diseases. Zoonotic diseases are threatening as the population does not have natural nor artificial (from vaccination) immune response to new diseases like in the Ebola Virus Disease outbreak in 2014. The new strain of the Ebola Virus in West Africa was slightly less lethal, compared to other Ebola Virus strains, but the threat of spreading was far bigger as it had a longer incubation time. Most public health systems are not trained well enough to mitigate highly infectious and deadly disease outbreaks. NGO’s helping to fight the outbreak are often better trained in curative treatments and have less experience with biological (bioweapon) threats for which the military are trained for. The UNMEER mission was unique in this. It was a setting in which military and civilian actors cooperate in fighting a biological threat. Protection is essential for health workers. Smart systems must be developed to prevent further spreading of the disease, but it is not only the biosafety, which has to be considered, but also the biosecurity, as misuse of extremely dangerous strains of microorganisms cannot be excluded. Several zoonotic infectious diseases, like anthrax, smallpox and hemorrhagic fevers are listed as potential bioweapons. Therefor both biosafety and biosecurity have to be implemented in all measures to fight outbreaks of highly infectious diseases. 

Recent publications

1.   Moon S et. al. (2015)  Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola. Lancet. 386(100069): 2204-21.

2.   Kamradt-Scott A et. al. (2015) WHO must remain a strong global health leader post Ebola. Lancet 385(9963):111.

3.   Kieny MP, Dovlo D (2015) Beyond Ebola: a new agenda for resilient health systems. Lancet 385(9963):91-92.

4.   Cenciarelli O et. al. (2015) Viral bioterrorism: Learning the lesson of Ebola virus in West Africa 2013-2015. Virus Research 210: 318-326.

5.   Abramowitz SA et. al. (2015) Social science intelligence in the global Ebola response. Lancet 385(9965): 330.